A federal judge in Manhattan heard arguments Tuesday in a lawsuit questioning the patentability of human genes.

The case, Association for Molecular Pathology v. U.S. Patent and Trademark Office, 09-civ-4515, centers on whether genes, once separated from the lengthy DNA sequence, are sufficiently “new and useful” to be deemed patentable under federal patent law.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]